News Archive

Events for the below selected month

Effectiveness of Surgical and Cotton Masks in Blocking SARS–CoV-2

Posted

07 April 2020

A Controlled Comparison in 4 Patients

Background: During respiratory viral infection, face masks are thought to prevent transmission (1). Whether face masks worn by patients with coronavirus disease 2019 (COVID-19) prevent contamination of the environment is uncertain (2, 3). A previous...

Proposal for a UK Head & Neck Oncology Collaborative

Posted

31 March 2020

Message from the President of BAHNO to members

We are all working in a period of unprecedented demand and there is no doubt that the management of many patients with head and neck cancer will have to be modified during the current COVID-19 crisis. The ability for us to treat these patients will...

Urgent cancer research needing H&N Surgeons

Posted

30 March 2020

COVID SURG CANCER

Urgent Cancer Research needing H&N Surgeons. COVID SURG CANCER - a National/International cohort study has opened, assessing the impact of COVID19 on Surgery, and more specifically for us, on Head & Neck Surgery. Following the suspension of...

Message from IFHNOS

Posted

30 March 2020

Impact of Covid-19 on IFHNOS

Dear Colleagues, From the massive catastrophe created by the Covid-19 Pandemic around the world, we all are in the midst of its impact on ourselves, our family and friends and our societies in general. The aftermath of this pandemic will last for...

Guidance for reinsertion of TEP voice prostheses

Posted

25 March 2020

BAHNO proposed guidance during the COVID-19 pandemic

BAHNO recognises that the management of many patients with cancer will have to be modified during the current COVID-19 crisis. One particulat group that may cause management dilemmas are those with voice prostheses. Please click here for the...

Proposed guidance for laryngectomy surgery during the COVID-19 pandemic

Posted

24 March 2020

To UK Head and Neck MDTs

Please click here for the BAHNO proposed guidance for laryngectomy surgery during the COVID 19 pandemic

Coronavirus vaccines

Posted

24 March 2020

Five key questions as trials begin

Some experts warn that accelerated testing will involve some risky trade-offs. Article in Nature Research Journal

BAHNO Statement on COVID-19

Posted

23 March 2020

Please click here for the BAHNO Statement on COVID-19. Initial guidance for head and neck cancer management during Covid-10 pandemic, in consultation with ENTUK. BAOMS endorsement awaited.

Transmission routes of 2019-nCoV

Posted

19 March 2020

Controls in dental practice

The International Journal of Oral Science has the following article: A novel β-coronavirus (2019-nCoV) caused severe and even fetal pneumonia explored in a seafood market of Wuhan city, Hubei province, China, and rapidly spread to other provinces...

MHRA advice

Posted

16 March 2020

Advice for management of clinical trials in relation to Coronavirus

Latest advice from MHRA available on their website

Coronavirus (COVID-19)

Posted

14 March 2020

Announcement from The Royal College of Surgeons

In response to COVID-19, The Royal College of Surgeons has announced they are cancelling or postponing some exams, courses and other activites to minimise the risk to key medical professionals. See their website for more...

Throat Cancer Foundation

Posted

19 February 2020

New ambassador announced

The Throat Cancer Foundation is delighted to announce that internationally award-winning jewellery designer Shaun Leane has joined the organisation as an ambassador. International jewellery designer to royalty and celebrities, Shaun Leane has...

Making Sense Campaign

Posted

06 December 2019

Report of 2019 activities

Highlights from the global Making Sense Campaign this year have been published - congratulations to the UK team headed by BAHNO Public Engagement Committee led by Professor Anastasios Kanatas! The report is available here.

Use of Pembrolizumab

Posted

27 November 2019

Article in The Lancet

According to this research, pembrolizumab plus platinum and 5-fluorouracil is an appropriate first-line treatment for recurrent or metastatic HNSCC and pembrolizumab monotherapy is an appropriate first-line treatment for PD-L1-positive recurrent or...

Why so many with throat cancer dread Christmas

Posted

26 November 2019

Press release from Throat Cancer Foundation

‘Eat, drink and be merry,’ is the commandment that most people live by when it comes to Christmas. However, for those living with throat cancer, it can be the most dreaded time of the year as what we all take for granted, such as eating and...

Guidelines for the use of drugs in sympton control

Posted

04 November 2019

West Midlands Palliative Care Physicians Current Practice

The West Midlands Palliative Care Physicians have published new guidlelines for the use of drugs in sympton control. These may be accessed here

Carols at Christmas

Posted

30 October 2019

with Saving Faces

The annual ‘Carols at Christmas’ concert by Saving Faces will take place on Wednesday 18th December 2019 at 6.30pm at the Priory Church of Saint Bartholomew the Great, one of London’s oldest churches. The Chelsea Opera Group will be singing and...

Communicating about HPV in the context of Head & Neck Cancer

Posted

07 October 2019

A systematic review of quantative studies

Information deficits, communication challenges and barriers to discussing HPV were identified in HNC patient-provider consultations. Read this abstract in full on the ScienceDirect website: Abstract Objective Rising incidence of...

Repurposed quinacrine synergizes with cisplatin

Posted

26 September 2019

Study shows that quinacrine is able to reduce cell growth

Despite highly toxic treatments, head and neck squamous cell carcinoma (HNSCC) have poor outcomes. There is an unmet need for more effective, less toxic therapies. Repurposing of clinically-approved drugs, with known safety profiles, may provide a...

The 2nd Kathmandu Head & Neck Reconstructive Surgery Course

Posted

25 September 2019

1st -2nd October 2019

This course is accredited by the Royal College of Surgeons of Edinburgh and has an impressive UK faculty. Further details available here.

Back to News Home